- Home
- LAB vs NCV Comparison
LAB vs NCV Comparison
Compare LAB & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- NCV
- Stock Information
- Founded
- LAB 1999
- NCV 2003
- Country
- LAB United States
- NCV United States
- Employees
- LAB N/A
- NCV N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- NCV Finance Companies
- Sector
- LAB Industrials
- NCV Finance
- Exchange
- LAB Nasdaq
- NCV Nasdaq
- Market Cap
- LAB 372.1M
- NCV 305.7M
- IPO Year
- LAB 2011
- NCV N/A
- Fundamental
- Price
- LAB $1.05
- NCV $13.53
- Analyst Decision
- LAB Buy
- NCV
- Analyst Count
- LAB 2
- NCV 0
- Target Price
- LAB $2.50
- NCV N/A
- AVG Volume (30 Days)
- LAB 1.3M
- NCV 405.1K
- Earning Date
- LAB 07-30-2025
- NCV 01-01-0001
- Dividend Yield
- LAB N/A
- NCV 12.48%
- EPS Growth
- LAB N/A
- NCV N/A
- EPS
- LAB N/A
- NCV N/A
- Revenue
- LAB $169,687,000.00
- NCV N/A
- Revenue This Year
- LAB N/A
- NCV N/A
- Revenue Next Year
- LAB $12.18
- NCV N/A
- P/E Ratio
- LAB N/A
- NCV N/A
- Revenue Growth
- LAB 33.86
- NCV N/A
- 52 Week Low
- LAB $0.92
- NCV $2.84
- 52 Week High
- LAB $2.41
- NCV $3.59
- Technical
- Relative Strength Index (RSI)
- LAB 48.48
- NCV 53.45
- Support Level
- LAB $1.02
- NCV $13.45
- Resistance Level
- LAB $1.12
- NCV $13.68
- Average True Range (ATR)
- LAB 0.07
- NCV 0.13
- MACD
- LAB 0.00
- NCV -0.03
- Stochastic Oscillator
- LAB 46.67
- NCV 30.67
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.